Kymera Therapeutics Inc KYMR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/02/24 EDT
36.30UNCH (UNCH)
Volume
16,310
Close
36.30UNCH (UNCH)
Volume
486,349
52 week range
9.60 - 45.31
Loading...
  • Open36.17
  • Day High36.83
  • Day Low35.06
  • Prev Close36.24
  • 52 Week High45.31
  • 52 Week High Date02/27/24
  • 52 Week Low9.60
  • 52 Week Low Date11/02/23

Key Stats

  • Market Cap2.227B
  • Shares Out61.36M
  • 10 Day Average Volume0.53M
  • Dividend-
  • Dividend Yield-
  • Beta2.30
  • YTD % Change42.58

KEY STATS

  • Open36.17
  • Day High36.83
  • Day Low35.06
  • Prev Close36.24
  • 52 Week High45.31
  • 52 Week High Date02/27/24
  • 52 Week Low9.60
  • 52 Week Low Date11/02/23
  • Market Cap2.227B
  • Shares Out61.36M
  • 10 Day Average Volume0.53M
  • Dividend-
  • Dividend Yield-
  • Beta2.30
  • YTD % Change42.58

RATIOS/PROFITABILITY

  • EPS (TTM)-2.52
  • P/E (TTM)-14.41
  • Fwd P/E (NTM)-11.54
  • EBITDA (TTM)-161.43M
  • ROE (TTM)-33.21%
  • Revenue (TTM)78.592M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-186.99%
  • Debt To Equity (MRQ)0.65%

EVENTS

  • Earnings Date05/02/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kymera Therapeutics Inc

Profile

MORE
Kymera Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. The Company's targeted protein degradation (TPD) platform, which it refers to as Pegasus, allows it to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout...
Bruce Booth Ph.D.
Independent Chairman of the Board
Nello Mainolfi Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Jeremy Chadwick Ph.D.
Chief Operating Officer
Bruce Jacobs
Chief Financial Officer
Address
500 North Beacon Street, 4Th Floor
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
ARVN
Arvinas Inc
32.43UNCHUNCH
NTLA
Intellia Therapeutics Inc
23.27UNCHUNCH
RYTM
Rhythm Pharmaceuticals Inc
40.98UNCHUNCH
RXRX
Recursion Pharmaceuticals Inc
8.79UNCHUNCH
CLDX
Celldex Therapeutics Inc
40.86UNCHUNCH